Takeda Pharmaceutical Co

Just moments ago, a Food and Drug Administration (FDA) panel said that clinical data concerning GlaxoSmithKline plc's (NYSE: GSK) diabetes drug, Avandia, is strong enough to raise "significant safety" concerns about the product. Specifically, Dow Jones is reporting that “the current FDA panel voted...